California Forum on Hepatitis C Screening and Treatment

 

California Forum on Hepatitis C Screening and Treatment
                            Friday, November 8, 2013
                                      Oakland, CA

 

The U.S. Centers for Disease Control and Prevention (CDC), Viral Hepatitis Action Coalition at the CDC Foundation, California Department of Public Health (CDPH), Infectious Diseases Society of America, and Association for the Advanced Study of Liver Diseases cohosted a forum of more than 60 providers, academic medical specialists, pharmacists, laboratory representatives, health plans, and medical and professional organizations to develop strategies for improving hepatitis C screening and care in primary care settings in California. CDPH will be working with community partners to establish a statewide hepatitis C learning collaborative and quality improvement network to put into practice recommendations from the forum.

     Agenda

 

Welcome and Goals for Forum
George Flores, MD, Senior Program Officer of Health Communities, California Endowment, California Endowment

CDC and U.S. Preventive Services Task Force HCV Screening Recommendations and the HCV Treatment Cascade
(slides)
John Ward, MD, Director, Viral Hepatitis Program, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC

Hepatitis C Costs and Consequences in California
(slides)
Rachel McLean, MPH, Chief, Office of Viral Hepatitis Prevention; STD Health Care Policy Analyst, STD Control Branch, CDPH

Opportunities for Leveraging the Affordable Care Act to Support HCV Screening and Linkages to Care

Kathleen Clanon, MD, FACP, Medical Director, Health Program of Alameda County (slides) and
Ryan Clary, Policy Director, National Viral Hepatitis Roundtable (slides)

HCV Screening and Linkages to Care in Primary Care and Other Health Care Settings in California

Michael Allerton, MS, Practice Leader, Infectious Diseases, Medical Group Administration, Kaiser Permanente of Northern California (slides),
Sally Slome, MD, Chief, Infectious Diseases, Kaiser Permanente Medical Group, Oakland, and
Mark Dressner, MD, President, California Academy of Family Physicians (slides)

Advances in HCV Treatment: The Potential for Hepatitis C Clinical Management and Treatment in Primary Care and Other Health Care Settings
(slides)
Robert Gish, MD, Robert G Gish Consultants LLC, San Diego

Models and Resources for Increasing HCV Clinical Management Capacity in Primary Care and Other Health Care Settings

Kent Unruh, PhD, Operations Director, University of Washington Project ECHO (slides),
Lorenzo Rossaro, MD, Chief of Gastroenterology and Hepatology, University of California Davis (slides),
C. Brad Hare, MD, Associate Professor of Medicine, University of California San Francisco, and
Wells Shoemaker, MD, Medical Director, California Association of Physician Groups (slides)

HCV Clinical Management and Treatment in Primary Care and Other Health Care Settings in California

Robert “Chip” Schooley, MD, Chief, Division of Infectious Diseases, University of California San Diego,
David Hardy, MD, Director, Infectious Disease, David Geffen School of Medicine, University of California Los Angeles,
Gail Nickerson, California Association of Rural Health Clinics, and
Pamela Madala, FNP, MSN, MEdAd, Director, Chronic Hepatitis Management and Telehepatology Programs, Adventist Health Community Care (slides)

Building a Hepatitis C Screening and Care Collaborative Learning and Quality Improvement Network

James Watt, MD, MPH, Chief, Division of Communicable Disease Control, California Department of Public Health (slides), and
Rachel McLean, MPH, Viral Hepatitis Prevention Coordinator/STD Healthcare Policy Analyst, CDPH (slides)

Next Steps, Closing Remarks

John Ward, MD, Director, Viral Hepatitis Program,
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC

 

Supporting Materials: